Search

It's better to have fewer, stronger, spin-offs than shoals of tiddlers, as Marina Murphy discovers.

The UK government has announced the formation of two further Enterprise Capital Funds, one more than it intended to set up in the first phase of the programme.

Battery capacity has been blamed for holding back innovation in many fields, from renewable energy to mobiles. Now nanotech is providing the answer.

The Cambridge-MIT Institute has spun out its Communications Research Network project as a company to step up the pace of innovation in communications.

Economic disparity across Europe's regions can be linked directly to investment in research and development and adoption of information technologies, says an official report.

With the end of easy oil, French oil services giant Schlumberger Clamart Technology Centre is transforming its research and development activities.

Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

USA Today reports declining R&D budgets in the USA, albeit in, it seems, just one tech sector.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.

It may have started from a low base, but the Indian biotech industry is hurtling past the global growth rate. And overseas companies are anxious to get in on the action.

Indian firms are training large numbers of patent agents - with their eye on the large number of companies abroad looking for cheaper patenting.

Universities in Ireland can now bid for funds to beef up their knowledge transfer activities.

Advances in neuroscience are opening up the treatment options for central nervous system diseases - at the same time as the ageing population is increasing the market for these products.

Drug companies finally have an incentive to carry out safety testing in children following new EU legislation approved last week.

The Open Source software movement has broken the stranglehold of expensive, proprietary products. Could the same thing happen in biotechnology?

Scientists from the University of Birmingham, UK, have powered a fuel cell from confectionary waste. They now want to form a consortium with investors and SMEs to apply for an EU Framework grant.

Microsoft Corp. is spinning out some of its software technology to two small European tech ventures, as part of a program to speed development of innovations from its labs.

Europabio thinks that Europe is doing a poor job when it comes to investing in biotechnology.